Tirzepetide
Tirzepatide is a novel peptide that has garnered significant attention in the research community for its potential applications in metabolic and weight management studies. As a dual-action agonist for both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, Tirzepatide offers a unique mechanism of action for researchers exploring the intricacies of metabolic pathways. Studies have shown its potential to influence appetite, energy expenditure, and insulin sensitivity, making it a valuable compound for investigating obesity and type 2 diabetes. Its multifaceted effects on the endocrine system provide a rich area for further research into its metabolic benefits. Includes bacteriostatic water. For research purposes only. Not for human consumption.
Key Research Benefits
- Investigate dual GIP and GLP-1 receptor agonism
- Study potential for significant weight loss and appetite regulation
- Research applications in glycemic control and insulin sensitivity
- Explore metabolic pathways related to obesity and type 2 diabetes
- High purity and stability for reliable and reproducible results
Select Dosage
Quantity
Bacteriostatic water included with every order for convenient reconstitution.
Note: Product images are for illustration purposes only. Vials are supplied unlabelled.